Join
Live feed
·
PRReleasevia Quantisnow
Oncocyte Corporation logo

Oncocyte Selected as New "Day One" Launch Site for QIAGEN's Companion Diagnostics Test to Identify Patients for Amgen's Newly FDA-Approved Drug LUMAKRAS (Sotorasib) For Advanced Stage Lung Cancer

ByQuantisnow·Wall Street's wire, on your screen.
OCX· Oncocyte Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.